Salvatore Piscuoglio at University of Basel - Research Interests, Publications & Academic Profile

Salvatore Piscuoglio

University of Basel

Switzerland

Has grant

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

Send an email

ORCID

Google Scholar

Research Interests

Cell Biology

100%

Biostatistics

60%

Cancer Biology

100%

Tumor Heterogeneity

30%

Hepatology

30%

Liquid Biopsy

30%

Genomic

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Recent Grants

Grant: Close

Disease monitoring of hepatocellular carcinoma undergoing sorafenib treatment using plasma-derived cell-free DNA

Open Date: 2018-09-01

Close Date: 2019-09-01

Grant: Close

Disease monitoring of hepatocellular carcinoma undergoing sorafenib treatment using plasma-derived cell-free DNA

Open Date: 2018-09-01

Close Date: 2019-09-01

Grant: Close

Identification of molecular targets in hepatocellular carcinomas associated with HMGA1 overexpression

Open Date: 2017-03-01

Close Date: 2019-04-01

Grant: Close

Long non-coding RNAs in triple negative breast cancers

Open Date: 2017-01-01

Close Date: 2019-12-01

Grant: Close

The feasibility of genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients

Open Date: 2017-01-01

Close Date: 2018-08-01

Articles20

Hepatocellular Carcinoma Immune Microenvironment Analysis: A Comprehensive Assessment with Computational and Classical Pathology

Article Link

Year:

2024

Probabilistic pathway-based multimodal factor analysis

Article Link

Year:

2024

Extracellular Vesicle DNA Extraction and Sequencing in Ancient Serum Samples From Patients With Breast Cancer.

Article Link

Year:

2024

In vivo interaction screening reveals liver-derived constraints to metastasis.

Article Link

Year:

2024

Ribosomal protein RPL39L is an efficiency factor in the cotranslational folding of a subset of proteins with alpha helical domains.

Article Link

Year:

2024

Tracing Tumor Heterogeneity of Pleomorphic Carcinoma of the Lung.

Article Link

Year:

2024

A Hepatocellular Cancer Patient-derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth.

Article Link

Year:

2024

Early Age of Onset Is an Independent Predictor for a Worse Response to Neoadjuvant Therapies in Sporadic Rectal Cancer Patients.

Article Link

Year:

2023

PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition.

Article Link

Year:

2023

Colitis Is Associated with Loss of the Histidine Phosphatase LHPP and Upregulation of Histidine Phosphorylation in Intestinal Epithelial Cells

Article Link

Year:

2023

DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

Article Link

Year:

2023

PipeIT2: A tumor-only somatic variant calling workflow for molecular diagnostic Ion Torrent sequencing data.

Article Link

Year:

2023

Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer

Article Link

Year:

2023

Analysis of off-tumour toxicities of T-cell-engaging bispecific antibodies via donor-matched intestinal organoids and tumouroids.

Article Link

Year:

2023

Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer

Article Link

Year:

2023

Live slow-frozen human tumor tissues viable for 2D, 3D, ex vivo cultures and single-cell RNAseq

Article Link

Year:

2022

Discovery of synthetic lethal interactions from large-scale pan-cancer perturbation screens

Article Link

Year:

2022

The prognostic significance of CXCR4 and SDF-1 in differentiated thyroid cancer depends on CD8+ density.

Article Link

Year:

2022

Response by du Fay de Lavallaz et al to Letter Regarding Article, “Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T”

Article Link

Year:

2022

PD-L1 Expression in Triple-negative Breast Cancer-a Comparative Study of 3 Different Antibodies.

Article Link

Year:

2022

Collaborators13

Armando Santoro

Professore

Humanitas University

ITALY

Michael Krauthammer

Professor

University of Zurich

SWITZERLAND

Michael N Hall

Professor

Universität Basel Department Biozentrum

SWITZERLAND

Michael Prummer

Head of Biostatistics

ETH Zürich

SWITZERLAND

Julijana Ivanisevic

Head of Metabolomics Unit / Senior Lecturer

University of Lausanne, Faculty of Biology and Medicine

SWITZERLAND

luca di tommaso

Associate professor of Pathology

Humanitas University

ITALY

Mark A. Rubin

University of Bern

SWITZERLAND

Gaetana Restivo

University of Zurich

SWITZERLAND

Arnoud Templeton

University of Basel

SWITZERLAND

Antonino Spinelli

Full Professor od Surgery

Humanitas University

ITALY

Salvatore Lorenzo Renne

Assistant Professor

Humanitas University

ITALY

Mohamed Bentires-Alj

Professor of experimental surgical oncology

University of Basel

SWITZERLAND

Marcus Vetter

University Hospital Basel

SWITZERLAND

How do Nigerian students reach out?

Meet Kite AI